Terms: = Breast cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Clinical Outcome
9 results:
1. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract] [Full Text] [Related]
2. clinical relevance of H-RAS, k-ras, and n-ras mRNA expression in primary breast cancer patients.
Banys-Paluchowski M; Milde-Langosch K; Fehm T; Witzel I; Oliveira-Ferrer L; Schmalfeldt B; Müller V
Breast Cancer Res Treat; 2020 Jan; 179(2):403-414. PubMed ID: 31646390
[TBL] [Abstract] [Full Text] [Related]
3. Molecular characterization of metaplastic breast carcinoma via next-generation sequencing.
Zhai J; Giannini G; Ewalt MD; Zhang EY; Invernizzi M; Niland J; Lai LL
Hum Pathol; 2019 Apr; 86():85-92. PubMed ID: 30537493
[TBL] [Abstract] [Full Text] [Related]
4. Genomic Profiling of Thyroid cancer Reveals a Role for Thyroglobulin in Metastasis.
Siraj AK; Masoodi T; Bu R; Beg S; Al-Sobhi SS; Al-Dayel F; Al-Dawish M; Alkuraya FS; Al-Kuraya KS
Am J Hum Genet; 2016 Jun; 98(6):1170-1180. PubMed ID: 27236916
[TBL] [Abstract] [Full Text] [Related]
5. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract] [Full Text] [Related]
6. IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.
Roberti MP; Barrio MM; Bravo AI; Rocca YS; Arriaga JM; Bianchini M; Mordoh J; Levy EM
Breast Cancer Res Treat; 2011 Nov; 130(2):465-75. PubMed ID: 21308409
[TBL] [Abstract] [Full Text] [Related]
7. BRCA1, C-erbB-2, and H-ras gene expressions in young women with breast cancer. An immunohistochemical study.
Ozer E; Sis B; Ozen E; Sakizli M; Canda T; Sarioğlu S
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):12-8. PubMed ID: 10937043
[TBL] [Abstract] [Full Text] [Related]
8. H-ras gene amplification or mutation is not common in human primary breast cancer.
Schondorf T; Andrack A; Niederacher D; Scharl A; Becker M; Engel H; Gohring UJ
Oncol Rep; 1999; 6(5):1029-33. PubMed ID: 10425298
[TBL] [Abstract] [Full Text] [Related]
9. The H-ras oncogene product p21 and prognosis in human breast cancer.
Watson DM; Elton RA; Jack WJ; Dixon JM; Chetty U; Miller WR
Breast Cancer Res Treat; 1991; 17(3):161-9. PubMed ID: 2039838
[TBL] [Abstract] [Full Text] [Related]
